Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Stern

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Biology|October 1, 1995
The cellular response to neuregulins is governed by complex interactions of the erbB receptor familyD J Riese, T M van Raaij, G D Plowman, et al.
Oncogene|January 18, 1996
Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-betaD J Riese, Y Bermingham, T M van Raaij, et al.
Cell|November 17, 1989
The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domainA S Shaw, K E Amrein, C Hammond, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1985
Type beta transforming growth factor: a bifunctional regulator of cellular growthA B Roberts, M A Anzano, L M Wakefield, et al.
Oncogene|October 20, 1998
Active signaling by Neu in transgenic miceM P DiGiovanna, M A Lerman, R J Coffey, et al.
The Journal of Biological Chemistry|August 16, 1996
The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4D J Riese, E D Kim, K Elenius, et al.
Experimental and Molecular Pathology|June 22, 2001
Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptorsE B Claus, P Chu, C L Howe, et al.
Nature|December 6, 1984
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenA L Schechter, D F Stern, L Vaidyanathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Cancer Gene Therapy|June 11, 2011
DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatomaG Singhal, M Z Akhter, D F Stern, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Biology|October 1, 1995
The cellular response to neuregulins is governed by complex interactions of the erbB receptor familyD J Riese, T M van Raaij, G D Plowman, et al.
Oncogene|January 18, 1996
Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-betaD J Riese, Y Bermingham, T M van Raaij, et al.
Cell|November 17, 1989
The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domainA S Shaw, K E Amrein, C Hammond, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1985
Type beta transforming growth factor: a bifunctional regulator of cellular growthA B Roberts, M A Anzano, L M Wakefield, et al.
Oncogene|October 20, 1998
Active signaling by Neu in transgenic miceM P DiGiovanna, M A Lerman, R J Coffey, et al.
The Journal of Biological Chemistry|August 16, 1996
The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4D J Riese, E D Kim, K Elenius, et al.
Experimental and Molecular Pathology|June 22, 2001
Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptorsE B Claus, P Chu, C L Howe, et al.
Nature|December 6, 1984
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigenA L Schechter, D F Stern, L Vaidyanathan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2000
Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancerA D Thor, S Liu, S Edgerton, et al.
Cancer Gene Therapy|June 11, 2011
DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatomaG Singhal, M Z Akhter, D F Stern, et al.
Pageof 7